Sophia Genetics Liabilities 2024

Sophia Genetics Aktienanalyse

What does Sophia Genetics do?

Sophia Genetics SA is a Swiss company that was founded in 2011. The idea behind it was to improve genome sequencing and data analysis in order to make faster and more precise medical diagnoses. Sophia Genetics has since become a leading provider of artificial intelligence and data analysis in the medical field. The business model of Sophia Genetics is based on providing doctors and medical facilities with corresponding data analysis tools and platforms. Sophia Genetics' algorithms help to identify genetic anomalies and develop personalized therapies. This personalized medicine aims to improve healthcare. Sophia Genetics is divided into various sectors. The core sectors include oncology, pediatrics, cardiology, and neurology. In these specialized fields, Sophia Genetics' platforms and tools are used to optimize genome sequencing and data analysis, thus enabling faster and more precise diagnoses. The company offers a variety of products that help doctors and medical facilities create successful diagnoses and therapies. Sophia Genetics' flagship product is the Sophia Artificial Intelligence (AI) platform. This platform is used by doctors, clinics, and research institutions to analyze complex data and identify the genetic causes of diseases. The Sophia AI platform provides fast, precise, and secure genome sequencing and data analysis. Sophia Genetics also offers the Sophia DDM system. The DDM system is a cloud-based data exchange system that provides doctors and medical facilities with a secure way to exchange confidential medical data. The system also allows for the collection and analysis of information about diseases and disease progression in the population, in order to enable better healthcare. Another important product of Sophia Genetics is the Sophia Hereditary Cancer Solution. This product helps in the early detection of hereditary cancer. The Sophia Hereditary Cancer Solution provides fast and precise genetic diagnostics to identify family members at increased risk of cancer and take appropriate measures. Another product of Sophia Genetics is Sophia Radiomics. This software uses artificial intelligence and machine learning to detect and characterize diseases based on X-ray and CT scans. By analyzing large amounts of data, the Sophia Radiomics software can assist doctors in making more precise diagnoses and better treatment decisions. Sophia Genetics relies on close collaboration with medical facilities and research institutions worldwide. The company now has customers in over 60 countries and is a partner to more than 1,000 hospitals worldwide. Sophia Genetics' platforms and tools have already helped many people to be diagnosed and treated faster and more accurately. Overall, Sophia Genetics is an innovative company that has revolutionized medical diagnostics. With its advanced platforms and tools, the company provides doctors and medical facilities with an excellent opportunity to develop personalized therapies and enable better healthcare. Please write only the answer in the output. Sophia Genetics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Sophia Genetics's Liabilities

Sophia Genetics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sophia Genetics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Sophia Genetics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Sophia Genetics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Sophia Genetics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Sophia Genetics stock

What is the level of liabilities of Sophia Genetics this year?

Sophia Genetics has a debt balance of 54.71 M USD this year.

What were the liabilities of Sophia Genetics compared to the previous year?

The liabilities of Sophia Genetics have increased by 25.2% increased compared to the previous year.

What are the consequences of high debt for investors of Sophia Genetics?

High liabilities can pose a risk for investors of Sophia Genetics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Sophia Genetics?

Low liabilities mean that Sophia Genetics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Sophia Genetics affect the company?

An increase in liabilities of Sophia Genetics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Sophia Genetics affect the company?

A decrease in the liabilities of Sophia Genetics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Sophia Genetics?

Some factors that can influence the liabilities of Sophia Genetics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Sophia Genetics so important for investors?

The liabilities of Sophia Genetics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Sophia Genetics take to modify the liabilities?

To change its liabilities, Sophia Genetics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Sophia Genetics pay?

Over the past 12 months, Sophia Genetics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sophia Genetics is expected to pay a dividend of 0 USD.

What is the dividend yield of Sophia Genetics?

The current dividend yield of Sophia Genetics is .

When does Sophia Genetics pay dividends?

Sophia Genetics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sophia Genetics?

Sophia Genetics paid dividends every year for the past 0 years.

What is the dividend of Sophia Genetics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sophia Genetics located?

Sophia Genetics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sophia Genetics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sophia Genetics from 9/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Sophia Genetics pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Sophia Genetics in the year 2023?

In the year 2023, Sophia Genetics distributed 0 USD as dividends.

In which currency does Sophia Genetics pay out the dividend?

The dividends of Sophia Genetics are distributed in USD.